April 29 (Reuters) -
Annovis Bio said on Monday that its Alzheimer's treatment showed significantly higher improvement in cognition in Alzheimer's patients during a mid-stage trial. (Reporting by Christy Santhosh; Editing by Vijay Kishore)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.28 USD | -0.36% | +19.80% | -56.11% |
April 29 (Reuters) -
Annovis Bio said on Monday that its Alzheimer's treatment showed significantly higher improvement in cognition in Alzheimer's patients during a mid-stage trial. (Reporting by Christy Santhosh; Editing by Vijay Kishore)
1st Jan change | Capi. | |
---|---|---|
-56.11% | 92.83M | |
+9.81% | 115B | |
+11.79% | 106B | |
-2.59% | 21.96B | |
-13.48% | 21.87B | |
-5.29% | 19.21B | |
-2.78% | 18.08B | |
-38.57% | 17.71B | |
+6.28% | 14.32B | |
+34.10% | 12.42B |